ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomioma - hipofīzes un hipotalāma hormoni un analogi - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
kliane 1 mg/2 mg apvalkotās tabletes
bayer ag, germany - norethisteroni acetas, estradiolum hemihydricum - apvalkotās tabletes - 1 mg/2 mg
aivareta 0,03 mg/3 mg apvalkotās tabletes
sandoz d.d., slovenia - ethinylestradiolum, drospirenonum - apvalkotā tablete - 0,03 mg/3 mg
aderjana 0,02 mg/3 mg apvalkotās tabletes
sandoz d.d., slovenia - ethinylestradiolum, drospirenonum - apvalkotā tablete - 0,02 mg/3 mg
calima 0,02 mg/3 mg apvalkotās tabletes
sandoz d.d., slovenia - ethinylestradiolum, drospirenonum - apvalkotā tablete - 0,02 mg/3 mg
diener 0,03 mg/2 mg apvalkotās tabletes
laboratorios leon farma s.a., spain - ethinylestradiolum, dienogestum - apvalkotā tablete - 0,03 mg/2 mg
cleodette 0,02 mg/3 mg 28 apvalkotās tabletes
actavis group ptc ehf., iceland - ethinylestradiolum, drospirenonum - apvalkotās tabletes - 0,02 mg/3 mg
logest 75 mikrogramu/20 mikrogramu apvalkotās tabletes
bayer ag, germany - ethinylestradiolum, gestodenum - apvalkotā tablete - 75 μg/20 μg
cleodette 0,03 mg/3 mg apvalkotās tabletes
actavis group ptc ehf., iceland - ethinylestradiolum, drospirenonum - apvalkotās tabletes - 0,03 mg/3 mg
cleodette 0,02 mg/3 mg apvalkotās tabletes
actavis group ptc ehf., iceland - ethinylestradiolum, drospirenonum - apvalkotās tabletes - 0,02 mg/3 mg